Karolina Karoń
Karolina Karoń has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Anna Zygmunt
Department of Pathology and Molecular Diagnostics, Medical University of Silesia in Katowice
11 shared publications - Wojciech Grabowski
Municipal Hospital in Zabrze
11 shared publications - Łukasz Karoń
Department of Pathology and Molecular Diagnostics, Medical University of Silesia in Katowice
11 shared publications - Daria Pedrycz
Department of Family Medicine, Medical University of Białystok
10 shared publications - Emilia Pedrycz
Wojewódzki Szpital Zespolony w Kielcach
10 shared publications - Grzegorz Drapała
Wojewódzki Szpital Zespolony w Kielcach
10 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by AME Publishing Company in Chinese Clinical Oncology
- Vol. 15 (2) , 37
Benign metastasizing leiomyoma: a systematic review of diagnosis, management, and outcomes
Background: Benign metastasizing leiomyoma (BML) is a rare complication of uterine fibroids, in which benign smooth muscle tumors spread to distant sites. Due to its rarity, clinical presentation and management remain insufficiently defined. This systematic review provides a comprehensive overview of BML. This study aimed to assess the clinical characteristics, treatment methods, and outcomes of patients with BML. Methods: The review included case reports, case series and review articles. A literature search was conducted in Google Scholar and PubMed using the keyword “benign metastasizing leiomyoma” from January 1, 2000 until March 31, 2024, yielding 310 articles from Google Scholar and 468 from PubMed. After removing duplicates and screening titles and abstracts, 213 articles were included. Data were systematically extracted on patient demographics, menopausal status, surgical history, tumor characteristics, imaging studies, histopathology, genetic tests, treatment methods and survival outcomes. Results: The mean age was 47.8 years, and 89 (32.1%) patients were asymptomatic. The most common symptoms were: cough (n=55, 29.3%), dyspnea (n=52, 27.7%) and abdominal pain (n=42, 22.3%). Metastatic lesions were primarily found in the lungs (n=235, 84.8%), followed by the peritoneum (n=40, 14.4%), vertebrae (n=17, 6.1%) and heart (n=15, 5.4%). Total and subtotal hysterectomy was performed in 180 (75.3%) and 26 (10.9%) patients, respectively. The majority of patients (n=239, 86.3%) underwent surgery, performed before BML diagnosis in 200 cases (83.7%) and after diagnosis in 39 cases (16.3%). The mean time between surgery and the diagnosis of BML was 101 months. The most common positive receptor expressions were for estrogen (n=181, 65.3%), progesterone (n=178, 64.3%) and desmin (n=129, 46.6%). Adjuvant treatment included predominant use of hormonal agents (n=82, 29.6%), while chemotherapy was rare (n=3, 3.8%). The mean follow-up was 18 months. Among the eight patients (2.9%) who died from BML progression, the disease was the direct cause of death in three (37.5%) cases. Conclusions: BML is a rare complication of uterine fibroids characterized by frequent pulmonary metastases, hormone receptor positivity, and variable clinical course. Hormonal therapy is the mainstay of adjuvant treatment, but disease progression and death can occur, highlighting the importance of individualized management and follow-up.
- 1 April 2026
- Published by AME Publishing Company in Chinese Clinical Oncology
- Vol. 15 (2) , 37
Open AccessBenign metastasizing leiomyoma: a systematic review of diagnosis, management, and outcomes
Background: Benign metastasizing leiomyoma (BML) is a rare complication of uterine fibroids, in which benign smooth muscle tumors spread to distant sites. Due to its rarity, clinical presentation and management remain insufficiently defined. This systematic review provides a comprehensive overview of BML. This study aimed to assess the clinical characteristics, treatment methods, and outcomes of patients with BML. Methods: The review included case reports, case series and review articles. A literature search was conducted in Google Scholar and PubMed using the keyword “benign metastasizing leiomyoma” from January 1, 2000 until March 31, 2024, yielding 310 articles from Google Scholar and 468 from PubMed. After removing duplicates and screening titles and abstracts, 213 articles were included. Data were systematically extracted on patient demographics, menopausal status, surgical history, tumor characteristics, imaging studies, histopathology, genetic tests, treatment methods and survival outcomes. Results: The mean age was 47.8 years, and 89 (32.1%) patients were asymptomatic. The most common symptoms were: cough (n=55, 29.3%), dyspnea (n=52, 27.7%) and abdominal pain (n=42, 22.3%). Metastatic lesions were primarily found in the lungs (n=235, 84.8%), followed by the peritoneum (n=40, 14.4%), vertebrae (n=17, 6.1%) and heart (n=15, 5.4%). Total and subtotal hysterectomy was performed in 180 (75.3%) and 26 (10.9%) patients, respectively. The majority of patients (n=239, 86.3%) underwent surgery, performed before BML diagnosis in 200 cases (83.7%) and after diagnosis in 39 cases (16.3%). The mean time between surgery and the diagnosis of BML was 101 months. The most common positive receptor expressions were for estrogen (n=181, 65.3%), progesterone (n=178, 64.3%) and desmin (n=129, 46.6%). Adjuvant treatment included predominant use of hormonal agents (n=82, 29.6%), while chemotherapy was rare (n=3, 3.8%). The mean follow-up was 18 months. Among the eight patients (2.9%) who died from BML progression, the disease was the direct cause of death in three (37.5%) cases. Conclusions: BML is a rare complication of uterine fibroids characterized by frequent pulmonary metastases, hormone receptor positivity, and variable clinical course. Hormonal therapy is the mainstay of adjuvant treatment, but disease progression and death can occur, highlighting the importance of individualized management and follow-up.
- Open Access
- 6 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 58309
Gut Microbiota and Insulin Resistance: Mechanisms, Therapeutic Strategies, and Future Directions
The gut microbiota, a complex ecosystem of microorganisms within the gastrointestinal tract, has emerged as a critical regulator of metabolic health. This review explores the intricate relationship between gut microbiota and insulin resistance, focusing on the underlying mechanisms, compositional changes, and therapeutic implications. Dysbiosis, characterized by reduced microbial diversity and an imbalance between beneficial and pathogenic species, contributes to insulin resistance through impaired short-chain fatty acid (SCFA) production, gut barrier dysfunction, and systemic inflammation. Key bacterial taxa, such as Akkermansia muciniphila and Faecalibacterium prausnitzii, play pivotal roles in maintaining metabolic homeostasis, while alterations in the Firmicutes-to-Bacteroidetes ratio and increased endotoxin production exacerbate metabolic dysfunction. Evidence suggests that modifiable factors, including diet, physical activity, and microbiota-targeted therapies like probiotics, prebiotics, and fecal microbiota transplantation (FMT), offer potential avenues for restoring microbial balance and mitigating insulin resistance. Despite advancements, research in this field faces challenges, including methodological variability, interindividual microbiota differences, and a need for standardized clinical approaches. Future studies should focus on long-term, large-scale interventional trials, personalized microbiota-based interventions, and elucidation of the gut microbiota's molecular mechanisms. This review underscores the promising role of gut microbiota in managing insulin resistance and highlights opportunities for integrating microbiota-targeted strategies into clinical practice.
- 6 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 58309
Open AccessGut Microbiota and Insulin Resistance: Mechanisms, Therapeutic Strategies, and Future Directions
The gut microbiota, a complex ecosystem of microorganisms within the gastrointestinal tract, has emerged as a critical regulator of metabolic health. This review explores the intricate relationship between gut microbiota and insulin resistance, focusing on the underlying mechanisms, compositional changes, and therapeutic implications. Dysbiosis, characterized by reduced microbial diversity and an imbalance between beneficial and pathogenic species, contributes to insulin resistance through impaired short-chain fatty acid (SCFA) production, gut barrier dysfunction, and systemic inflammation. Key bacterial taxa, such as Akkermansia muciniphila and Faecalibacterium prausnitzii, play pivotal roles in maintaining metabolic homeostasis, while alterations in the Firmicutes-to-Bacteroidetes ratio and increased endotoxin production exacerbate metabolic dysfunction. Evidence suggests that modifiable factors, including diet, physical activity, and microbiota-targeted therapies like probiotics, prebiotics, and fecal microbiota transplantation (FMT), offer potential avenues for restoring microbial balance and mitigating insulin resistance. Despite advancements, research in this field faces challenges, including methodological variability, interindividual microbiota differences, and a need for standardized clinical approaches. Future studies should focus on long-term, large-scale interventional trials, personalized microbiota-based interventions, and elucidation of the gut microbiota's molecular mechanisms. This review underscores the promising role of gut microbiota in managing insulin resistance and highlights opportunities for integrating microbiota-targeted strategies into clinical practice.
- Open Access
- 2 March 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 79, 58156
Tryptophan: The Molecular Key to Unlocking Superior Sleep, Mood Enhancement and Athletic Recovery
Tryptophan, an essential amino acid, plays a pivotal role in regulating sleep, mental health, athletic recovery and age-specific health conditions. Sleep, a fundamental biological process critical for physical and mental well-being, is intricately linked to the availability and metabolism of tryptophan. This amino acid serves as a precursor for serotonin, a neurotransmitter involved in mood regulation and melatonin, a hormone governing the sleep-wake cycle. Tryptophan’s conversion to serotonin and subsequent synthesis of melatonin underscore its influence on circadian rhythm stabilization and sleep quality enhancement. Emerging evidence supports the therapeutic potential of tryptophan supplementation in managing insomnia, optimizing recovery in athletes, and alleviating symptoms of irritable bowel syndrome (IBS). Its role in athletic recovery is particularly significant, as improved sleep quality accelerates tissue repair and enhances overall performance. Moreover, tryptophan demonstrates age-specific benefits, addressing sleep disturbances prevalent in older adults and contributing to improved mental health outcomes across various life stages. The modulation of serotoninergic pathways by tryptophan also underscores its broader implications for mood regulation and neuropsychiatric disorders.
- 2 March 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 79, 58156
Open AccessTryptophan: The Molecular Key to Unlocking Superior Sleep, Mood Enhancement and Athletic Recovery
Tryptophan, an essential amino acid, plays a pivotal role in regulating sleep, mental health, athletic recovery and age-specific health conditions. Sleep, a fundamental biological process critical for physical and mental well-being, is intricately linked to the availability and metabolism of tryptophan. This amino acid serves as a precursor for serotonin, a neurotransmitter involved in mood regulation and melatonin, a hormone governing the sleep-wake cycle. Tryptophan’s conversion to serotonin and subsequent synthesis of melatonin underscore its influence on circadian rhythm stabilization and sleep quality enhancement. Emerging evidence supports the therapeutic potential of tryptophan supplementation in managing insomnia, optimizing recovery in athletes, and alleviating symptoms of irritable bowel syndrome (IBS). Its role in athletic recovery is particularly significant, as improved sleep quality accelerates tissue repair and enhances overall performance. Moreover, tryptophan demonstrates age-specific benefits, addressing sleep disturbances prevalent in older adults and contributing to improved mental health outcomes across various life stages. The modulation of serotoninergic pathways by tryptophan also underscores its broader implications for mood regulation and neuropsychiatric disorders.
- Open Access
- 11 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 38, 58197
Citrulline – The Powerhouse Nutrient for Cardiometabolic and Brain Health
Citrulline, a non-essential amino acid and precursor to L-arginine, plays a pivotal role in nitric oxide (NO) synthesis, with profound implications for vascular health and neuroprotection. By enhancing NO production, citrulline supports endothelial function, vasodilation, and cerebral circulation, thereby mitigating cognitive decline associated with aging and neurodegenerative diseases. Unlike direct arginine supplementation, citrulline offers superior bioavailability, bypassing first-pass metabolism and achieving sustained plasma levels of arginine. Furthermore, citrulline's antioxidant properties counteract oxidative stress by modulating reactive oxygen species (ROS), reducing lipid peroxidation, and protecting neuronal integrity. Emerging evidence suggests its potential in delaying endothelial senescence and preventing ferroptosis, establishing its role in vascular and neuroprotective strategies. Dietary sources, such as watermelon juice, further enhance citrulline’s accessibility, combining its bioactivity with additional antioxidants like lycopene. While existing studies underscore its promise, targeted research is needed to confirm its direct impact on cognitive function and explore its application in neurodegenerative populations. This review synthesizes current knowledge on citrulline's mechanisms, therapeutic potential, and broader implications for aging and vascular health.
- 11 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 38, 58197
Open AccessCitrulline – The Powerhouse Nutrient for Cardiometabolic and Brain Health
Citrulline, a non-essential amino acid and precursor to L-arginine, plays a pivotal role in nitric oxide (NO) synthesis, with profound implications for vascular health and neuroprotection. By enhancing NO production, citrulline supports endothelial function, vasodilation, and cerebral circulation, thereby mitigating cognitive decline associated with aging and neurodegenerative diseases. Unlike direct arginine supplementation, citrulline offers superior bioavailability, bypassing first-pass metabolism and achieving sustained plasma levels of arginine. Furthermore, citrulline's antioxidant properties counteract oxidative stress by modulating reactive oxygen species (ROS), reducing lipid peroxidation, and protecting neuronal integrity. Emerging evidence suggests its potential in delaying endothelial senescence and preventing ferroptosis, establishing its role in vascular and neuroprotective strategies. Dietary sources, such as watermelon juice, further enhance citrulline’s accessibility, combining its bioactivity with additional antioxidants like lycopene. While existing studies underscore its promise, targeted research is needed to confirm its direct impact on cognitive function and explore its application in neurodegenerative populations. This review synthesizes current knowledge on citrulline's mechanisms, therapeutic potential, and broader implications for aging and vascular health.
- Open Access
- 5 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 78, 57570
Acne Vulgaris Management: A Review of First-Line and Advanced Pharmacological Treatments
Introduction and objective: Acne vulgaris is a common chronic inflammatory skin disease affecting hair and sebaceous follicles, characterized by skin lesions most commonly appearing on the face. Several factors predispose individuals to the development of acne, including hormonal imbalances, genetic predisposition, and the use of certain medications. This review aims to evaluate and summarize first-line and advanced pharmacological treatments for acne vulgaris, highlighting their efficacy, safety, and emerging therapies for optimal management. Review methods: The literature review utilized databases covering sources from PubMed, Google Scholar, Scopus, and Web of Science using the search terms encompassing the following keywords: ‘acne vulgaris’ and ‘topical retinoid therapy’, ‘benzoyl peroxide’, ‘azelaic acid’, ‘topical antibiotics’, ‘oral antibiotics’, ‘contraceptive agents’, ‘antiandrogen therapy’, ‘isotretinoin’. Brief description of the state of knowledge: Current treatment methods range from topical therapies (i.e. antibiotics and retinoids) for mild cases to systemic medications (i.e. antibiotics, retinoids, and hormonal) for moderate to severe acne. In most cases, treatment should start with topical therapy. Summary: Early intervention is crucial to mitigate the risk of scarring and psychosocial consequences. Emerging therapeutic strategies have the potential to enhance treatment outcomes.
- 5 February 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 78, 57570
Open AccessAcne Vulgaris Management: A Review of First-Line and Advanced Pharmacological Treatments
Introduction and objective: Acne vulgaris is a common chronic inflammatory skin disease affecting hair and sebaceous follicles, characterized by skin lesions most commonly appearing on the face. Several factors predispose individuals to the development of acne, including hormonal imbalances, genetic predisposition, and the use of certain medications. This review aims to evaluate and summarize first-line and advanced pharmacological treatments for acne vulgaris, highlighting their efficacy, safety, and emerging therapies for optimal management. Review methods: The literature review utilized databases covering sources from PubMed, Google Scholar, Scopus, and Web of Science using the search terms encompassing the following keywords: ‘acne vulgaris’ and ‘topical retinoid therapy’, ‘benzoyl peroxide’, ‘azelaic acid’, ‘topical antibiotics’, ‘oral antibiotics’, ‘contraceptive agents’, ‘antiandrogen therapy’, ‘isotretinoin’. Brief description of the state of knowledge: Current treatment methods range from topical therapies (i.e. antibiotics and retinoids) for mild cases to systemic medications (i.e. antibiotics, retinoids, and hormonal) for moderate to severe acne. In most cases, treatment should start with topical therapy. Summary: Early intervention is crucial to mitigate the risk of scarring and psychosocial consequences. Emerging therapeutic strategies have the potential to enhance treatment outcomes.
- Open Access
- 26 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 75, 56153
Targeting the Microbiome: The Role of Low-FODMAP Diet in Modulating Gut Health for IBS and Inflammatory Conditions
The Low-FODMAP diet has emerged as a key therapeutic intervention for managing irritable bowel syndrome (IBS), a prevalent gastrointestinal disorder characterized by recurrent abdominal pain and altered bowel habits. This study aims to evaluate the efficacy of the Low-FODMAP diet in alleviating IBS symptoms and to explore its potential as a broader therapeutic tool in other gastrointestinal disorders, including inflammatory conditions. Our review highlights significant improvements in symptom relief, notably in reducing bloating, pain, and bowel irregularities, which are commonly associated with IBS. The Low-FODMAP diet’s mechanisms of action, involving modulation of gut microbiota and reduction of osmotic effects, provide new insights into its impact on gastrointestinal health.Our findings underscore the Low-FODMAP diet’s potential applications beyond IBS, suggesting benefits in conditions such as inflammatory bowel disease (IBD) and small intestinal bacterial overgrowth (SIBO). However, the long-term impacts of this diet on gut microbiota composition, mental health, and immune function require further investigation. Future research should focus on these aspects, especially in relation to diet sustainability and microbial diversity. The clinical implications of this study encourage healthcare providers to consider the Low-FODMAP diet as a personalized, non-pharmacological option for gastrointestinal symptom management, with careful monitoring to ensure nutritional adequacy and individual patient needs.
- 26 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 75, 56153
Open AccessTargeting the Microbiome: The Role of Low-FODMAP Diet in Modulating Gut Health for IBS and Inflammatory Conditions
The Low-FODMAP diet has emerged as a key therapeutic intervention for managing irritable bowel syndrome (IBS), a prevalent gastrointestinal disorder characterized by recurrent abdominal pain and altered bowel habits. This study aims to evaluate the efficacy of the Low-FODMAP diet in alleviating IBS symptoms and to explore its potential as a broader therapeutic tool in other gastrointestinal disorders, including inflammatory conditions. Our review highlights significant improvements in symptom relief, notably in reducing bloating, pain, and bowel irregularities, which are commonly associated with IBS. The Low-FODMAP diet’s mechanisms of action, involving modulation of gut microbiota and reduction of osmotic effects, provide new insights into its impact on gastrointestinal health.Our findings underscore the Low-FODMAP diet’s potential applications beyond IBS, suggesting benefits in conditions such as inflammatory bowel disease (IBD) and small intestinal bacterial overgrowth (SIBO). However, the long-term impacts of this diet on gut microbiota composition, mental health, and immune function require further investigation. Future research should focus on these aspects, especially in relation to diet sustainability and microbial diversity. The clinical implications of this study encourage healthcare providers to consider the Low-FODMAP diet as a personalized, non-pharmacological option for gastrointestinal symptom management, with careful monitoring to ensure nutritional adequacy and individual patient needs.
- Open Access
- 17 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 33, 55778
Aromatic Serenity: How Lavender Eases Stress and Anxiety - A Literature Review
In today's fast-paced society, rising stress levels necessitate effective management strategies. While pharmacological treatments are common, their side effects have spurred interest in alternative therapies, particularly those rooted in natural remedies. Lavender (Lavandula angustifolia), long esteemed for its calming properties, has emerged as a promising non-pharmacological option. Historical use in herbal medicine for anxiety and stress-related disorders has inspired modern scientific research to explore its potential. This review synthesizes recent studies on lavender essential oil, examining its mechanisms—such as neurotransmitter modulation—and its effectiveness in diverse settings, from reducing stress among healthcare professionals to improving sleep quality. Despite promising results, limitations like small sample sizes and variability in application methods highlight the need for more rigorous research to establish lavender's efficacy and optimize its therapeutic use in stress management and mental health care.
- 17 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 33, 55778
Open AccessAromatic Serenity: How Lavender Eases Stress and Anxiety - A Literature Review
In today's fast-paced society, rising stress levels necessitate effective management strategies. While pharmacological treatments are common, their side effects have spurred interest in alternative therapies, particularly those rooted in natural remedies. Lavender (Lavandula angustifolia), long esteemed for its calming properties, has emerged as a promising non-pharmacological option. Historical use in herbal medicine for anxiety and stress-related disorders has inspired modern scientific research to explore its potential. This review synthesizes recent studies on lavender essential oil, examining its mechanisms—such as neurotransmitter modulation—and its effectiveness in diverse settings, from reducing stress among healthcare professionals to improving sleep quality. Despite promising results, limitations like small sample sizes and variability in application methods highlight the need for more rigorous research to establish lavender's efficacy and optimize its therapeutic use in stress management and mental health care.
- Open Access
- 17 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 33, 55867
L-arginine Supplementation in Endurance Athletes: A Systematic Review of Recovery Mechanisms and Performance Enhancement
L-arginine, a semi-essential amino acid, has garnered significant attention for its potential to enhance athletic performance, particularly within endurance sports. Recognized for its multifaceted roles in cardiovascular, immune, and metabolic functions, L-arginine serves as a precursor to biologically active molecules, including nitric oxide (NO), creatine, and polyamines, which are integral to muscle function and recovery. Through its ability to stimulate NO production, L-arginine promotes vasodilation, enhancing blood flow and oxygen delivery to active muscles, thereby improving exercise efficiency and endurance. Additionally, L-arginine influences muscle protein synthesis (MPS) via activation of the mTOR signaling pathway, aids in ammonia detoxification within the urea cycle, and supports cellular energetics by facilitating ATP production. These mechanisms collectively underscore its potential to support prolonged physical exertion, reduce muscle fatigue, and expedite post-exercise recovery. This systematic review examines current evidence on L-arginine supplementation in endurance athletes, focusing on its physiological impacts, mechanisms of action, and potential to enhance recovery and performance. Despite promising findings, variability in individual responses and mixed results across studies highlight the need for refined dosing strategies and further research into long-term safety and efficacy. This review provides a comprehensive overview of L-arginine's potential as a supplement in sports nutrition, aiming to inform evidence-based recommendations for its application in endurance training and recovery strategies.
- 17 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 33, 55867
Open AccessL-arginine Supplementation in Endurance Athletes: A Systematic Review of Recovery Mechanisms and Performance Enhancement
L-arginine, a semi-essential amino acid, has garnered significant attention for its potential to enhance athletic performance, particularly within endurance sports. Recognized for its multifaceted roles in cardiovascular, immune, and metabolic functions, L-arginine serves as a precursor to biologically active molecules, including nitric oxide (NO), creatine, and polyamines, which are integral to muscle function and recovery. Through its ability to stimulate NO production, L-arginine promotes vasodilation, enhancing blood flow and oxygen delivery to active muscles, thereby improving exercise efficiency and endurance. Additionally, L-arginine influences muscle protein synthesis (MPS) via activation of the mTOR signaling pathway, aids in ammonia detoxification within the urea cycle, and supports cellular energetics by facilitating ATP production. These mechanisms collectively underscore its potential to support prolonged physical exertion, reduce muscle fatigue, and expedite post-exercise recovery. This systematic review examines current evidence on L-arginine supplementation in endurance athletes, focusing on its physiological impacts, mechanisms of action, and potential to enhance recovery and performance. Despite promising findings, variability in individual responses and mixed results across studies highlight the need for refined dosing strategies and further research into long-term safety and efficacy. This review provides a comprehensive overview of L-arginine's potential as a supplement in sports nutrition, aiming to inform evidence-based recommendations for its application in endurance training and recovery strategies.
- Open Access
- 12 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 31, 55738
Allergy Modulation: Exploring the Role of Prebiotics, Probiotics, and Synbiotics in Enhancing Health Outcomes - A Literature Review
This literature review explores the role of prebiotics, probiotics, and synbiotics in the prevention and management of allergic diseases, including eczema, asthma, allergic rhinitis, and food allergies. The review delves into the mechanisms by which these dietary interventions modulate the gut microbiome, influence immune system responses, and enhance the epithelial barrier. While prebiotics promote the growth of beneficial gut bacteria and the production of short-chain fatty acids, probiotics introduce live microorganisms that restore balance in the gut ecosystem. Synbiotics combine both approaches to synergistically improve gut health. Despite the promising potential of these interventions, the evidence remains mixed, with their efficacy varying across different allergic conditions. This review underscores the need for further research to clarify the effectiveness of prebiotics, probiotics, and synbiotics in allergy prevention and management, highlighting the complexities involved in translating these findings into clinical practice.
- 12 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 31, 55738
Open AccessAllergy Modulation: Exploring the Role of Prebiotics, Probiotics, and Synbiotics in Enhancing Health Outcomes - A Literature Review
This literature review explores the role of prebiotics, probiotics, and synbiotics in the prevention and management of allergic diseases, including eczema, asthma, allergic rhinitis, and food allergies. The review delves into the mechanisms by which these dietary interventions modulate the gut microbiome, influence immune system responses, and enhance the epithelial barrier. While prebiotics promote the growth of beneficial gut bacteria and the production of short-chain fatty acids, probiotics introduce live microorganisms that restore balance in the gut ecosystem. Synbiotics combine both approaches to synergistically improve gut health. Despite the promising potential of these interventions, the evidence remains mixed, with their efficacy varying across different allergic conditions. This review underscores the need for further research to clarify the effectiveness of prebiotics, probiotics, and synbiotics in allergy prevention and management, highlighting the complexities involved in translating these findings into clinical practice.
- Open Access
- 26 October 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 70, 55722
Metabolic Reprogramming via Ketogenic Diet: A Novel Approach to Combating Neurological Diseases
Epilepsy is a chronic neurological disorder characterized by a persistent tendency for the brain to generate seizures, affecting approximately 0.5–1% of the global population. Despite advances in pharmacological treatments and surgical interventions, around 30% of individuals with epilepsy continue to experience seizures, leading to significant impacts on quality of life. Among these individuals, many suffer from drug-resistant epilepsy (DRE), where seizures persist despite optimal drug therapy or surgical interventions.In recent years, the ketogenic diet (KD)—a high-fat, low-carbohydrate dietary regimen—has emerged as an effective non-pharmacological strategy for managing DRE. The KD works by inducing ketosis, a metabolic state where the body uses fat as the primary energy source instead of carbohydrates, which has been associated with neuroprotective effects and significant seizure reduction. Variants of the KD, such as the Modified Atkins Diet (MAD) and Low Glycemic Index Treatment (LGIT), offer less restrictive alternatives that have shown similar efficacy in reducing seizure frequency.This review explores the cellular and molecular mechanisms of the KD, evaluates its safety and tolerability across different age groups, and assesses its efficacy in treating epilepsy, particularly DRE. The findings underscore the potential of personalized dietary interventions to serve as effective adjunctive therapies in the management of epilepsy, offering new hope for individuals who do not respond to conventional treatments.
- 26 October 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 70, 55722
Open AccessMetabolic Reprogramming via Ketogenic Diet: A Novel Approach to Combating Neurological Diseases
Epilepsy is a chronic neurological disorder characterized by a persistent tendency for the brain to generate seizures, affecting approximately 0.5–1% of the global population. Despite advances in pharmacological treatments and surgical interventions, around 30% of individuals with epilepsy continue to experience seizures, leading to significant impacts on quality of life. Among these individuals, many suffer from drug-resistant epilepsy (DRE), where seizures persist despite optimal drug therapy or surgical interventions.In recent years, the ketogenic diet (KD)—a high-fat, low-carbohydrate dietary regimen—has emerged as an effective non-pharmacological strategy for managing DRE. The KD works by inducing ketosis, a metabolic state where the body uses fat as the primary energy source instead of carbohydrates, which has been associated with neuroprotective effects and significant seizure reduction. Variants of the KD, such as the Modified Atkins Diet (MAD) and Low Glycemic Index Treatment (LGIT), offer less restrictive alternatives that have shown similar efficacy in reducing seizure frequency.This review explores the cellular and molecular mechanisms of the KD, evaluates its safety and tolerability across different age groups, and assesses its efficacy in treating epilepsy, particularly DRE. The findings underscore the potential of personalized dietary interventions to serve as effective adjunctive therapies in the management of epilepsy, offering new hope for individuals who do not respond to conventional treatments.